
Varizig
My Prescription
Payment
Select pharmacy




$2,546.43
$30.00 due at pharmacy
$2,546.43 - $30.00 = $2,516.43
$2,516.43 remaining balance
You will be given your coupon after you complete your purchase with PayPal.
$2,546.43
Print or send this coupon to your phone
About Varizig
Drug Details
Varizig is a medication designed to reduce the severity of chickenpox in individuals who are at high risk of serious illness after exposure to the varicella-zoster virus, which causes chickenpox. This medication is not a vaccine but an immune globulin containing antibodies that help the body fight the virus. Administered via injection into the muscle of the shoulder or upper thigh by a healthcare provider, Varizig is most effective when given within four days of exposure to the virus. Common side effects might include pain at the injection site and headache. Varizig is particularly useful for those who have not been vaccinated or previously infected by chickenpox and have recently come into contact with the virus. Routine vaccination remains the most effective way to prevent chickenpox. Always consult a healthcare professional before starting any new medication.
Price history for Varizig
1 Vial, 1.2ML of 125UNIT/1.2ML
Average retail price for Varizig
Average SaveHealth price for Varizig
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Varizig dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 1.2ML of 125UNIT/1.2ML | 1 Vial | $2,546.43 | $2,546.43 |
| 1.2ML of 125UNIT/1.2ML | 2 Vials | $5,069.57 | $2,534.79 |
| 1.2ML of 125UNIT/1.2ML | 3 Vials | $7,592.70 | $2,530.90 |
Varizig FAQs
VariZIG is used for post-exposure prophylaxis of varicella (chickenpox) in individuals who are at high risk for severe disease and complications. This includes immunocompromised individuals, pregnant women, newborns whose mothers have varicella shortly before or after delivery, and certain premature infants. It is administered to reduce the severity of the disease after exposure to the varicella-zoster virus.
VariZIG is not a vaccine. It is an immune globulin product used to provide passive immunity to individuals who have been exposed to the varicella-zoster virus, particularly those at high risk for severe complications.
Varicella-Zoster Immune Globulin (VZIG) is no longer available. It has been replaced by VariZIG, which is a similar product used for post-exposure prophylaxis of varicella (chickenpox) in high-risk individuals. VariZIG is available in the United States and can be obtained through specific distributors.
The cost of VariZIG can vary depending on the pharmacy, location, and insurance coverage. It is recommended to contact local pharmacies or healthcare providers for the most accurate and up-to-date pricing information. Additionally, checking with insurance providers can help determine if the cost is covered under a specific plan.
Varicella immunoglobulin is typically given to individuals who are at high risk for severe varicella (chickenpox) infection and have been exposed to the virus. This includes:1. Immunocompromised individuals, such as those undergoing chemotherapy or with certain immune disorders.2. Pregnant women who are not immune to varicella.3. Newborns whose mothers have signs and symptoms of varicella around the time of delivery.4. Premature infants born at or before 28 weeks of gestation or with a birth weight of 1000 grams or less, regardless of maternal immunity.5. Hospitalized premature infants born after 28 weeks of gestation whose mothers are not immune to varicella.These groups are prioritized to prevent severe complications from the infection.